Medications for HCV in Pediatric Patients | March 6, 2024
Date of Presentation: March 6, 2024
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #children #hcv #hcv monitoring #hcv testing #hep c #hepatitis #pediatrics #treatment
In this presentation, Dr. Paulina Deming discusses the latest guidance on HCV screening in pediatrics, as well recommendations for monitoring and management. Then, Dr. Deming discusses the available HCV medications recommended for use in pediatric patients, helpful tools, dosing, formulations and updated AASLD guidelines.
Recording:
Presented by:
Dr. Paulina Deming, PharmD, PhC
Dr. Paulina Deming, PharmD, is an Associate Professor-Clinical Educator within the Pharmacy Practice and Administrative Sciences Department at the College of Pharmacy at the University of New Mexico Health Sciences Center (UNMHSC). Dr. Deming completed a general practice residency and infectious diseases pharmacotherapy residency at UNMHSC. Her interests are focused in hepatitis C virus (HCV) infections and clinical therapeutics. She is the assistant director for the Project ECHO (Extension for Community Healthcare Outcomes) HCV clinic and serves on Project ECHO’s expert faculty panel advising providers on HCV care in community, corrections, and within the Indian Health Services settings. Licensed as a pharmacist clinician, she sees patients through the UNMHSC’s HCV clinic and the Truman HCV-HIV coinfection clinic. In addition to teaching and clinical work, Dr. Deming has co-authored papers on the management of HCV infections as well as HCV treatment outcomes in real-world settings.
Resources Provided:
Date added: February 27, 2024